An official website of the European UnionAn official EU website
Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 52019XC0308(01)

Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006) (Text with EEA relevance.)

C/2019/1577

OJ C 89, 8.3.2019, p. 11–11 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

8.3.2019   

EN

Official Journal of the European Union

C 89/11


Summary of European Commission Decisions on authorisations for the placing on the market for the use and/or for use of substances listed in Annex XIV to Regulation (EC) No 1907/2006 of the European Parliament and of the Council concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

(Published pursuant to Article 64(9) of Regulation (EC) No 1907/2006 (1) )

(Text with EEA relevance)

(2019/C 89/05)

Decisions granting an authorisation

Reference of the decision (2)

Date of decision

Substance name

Holder of the authorisation

Authorisation numbers

Authorised uses

Date of expiry of review period

Reasons for the decision

C(2019) 1577

1 March 2019

1,2-dichloroethane

EC No 203-458-1;

CAS No 107-06-2

OLON Spa, Strada Rivoltana Km 6/7, 20090, Rodano, Milano, Italy

REACH/19/1/0

Use as a solvent in the manufacturing of the active pharmaceutical ingredient epirubicin.

22 November 2029

In accordance with Article 60(4) of Regulation (EC) No 1907/2006, the socioeconomic benefits outweigh the risk to human health arising from the use of the substance and there are no suitable alternative substances or technologies in terms of their technical and economic feasibility for the applicant before the sunset date.

REACH/19/1/1

Use as a solvent in the manufacturing of the active pharmaceutical ingredient prednisolone steaglate.


(1)  OJ L 396, 30.12.2006, p. 1.

(2)  The decision is available on the European Commission website at: http://ec.europa.eu/growth/sectors/chemicals/reach/about/index_en.htm


Top